Back to search
FDAFDA · Food and drugs·Recall number D-0006-2017

Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10

Published October 12, 2016 · Recall initiated: September 2, 2016

Summary

FDA records drug Class III recall D-0006-2017, published October 12, 2016 and initiated September 2, 2016. Recalling firm: Shire; Status: Terminated; Reported quantity: 7,680 bottles (768,000 capsules); Lot: Lot # AF3360B; Exp. 04/19. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules

What to do

Voluntary: Firm initiated · Letter

Get an email if VYVANSE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
VYVANSE
Manufacturer
Shire
Distributor
Nationwide
Lot
Lot # AF3360B; Exp. 04/19
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10 recalled?

Yes. FDA published recall D-0006-2017 on October 12, 2016. Reported hazard: Presence of Foreign Tablets/Capsules

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: VYVANSE.